Physiological‐based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20‐years; in‐depth analysis of applications, organizations, and platforms-Reference-Cited by-同舟云学术

Physiological‐based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20‐years; in‐depth analysis of applications, organizations, and platforms

Published:2021-01-17 Issue:4 Volume:42 Page:107-117
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm Drug Dispos

Author:

El‐Khateeb Eman¹²^ORCID,Burkhill Susan³,Murby Susan¹,Amirat Hamza¹,Rostami‐Hodjegan Amin¹³^ORCID,Ahmad Amais¹^ORCID

Affiliation:

1. Centre for Applied Pharmacokinetic Research University of Manchester Manchester UK

2. Clinical Pharmacy Department Faculty of Pharmacy Tanta University Tanta Egypt

3. Certara UK Limited Sheffield UK

Funder

University of Manchester

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bdd.2257

Reference39 articles.

1. IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies

2. Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?

3. IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes

4. A computational systems biology software platform for multiscale modeling and simulation: Integrating whole‐body physiology, disease biology, and molecular reaction networks;Eissing T.;Frontiers in Physiology,2011

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A physiologically based pharmacokinetic model of voriconazole in human CNS—Integrating time-dependent inhibition of CYP3A4, genetic polymorphisms of CYP2C19 and possible transporter mechanisms;International Journal of Antimicrobial Agents;2024-10

2. Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration;European Journal of Pharmaceutical Sciences;2024-09

3. A physiologically‐based pharmacokinetic modeling approach for dosing amiodarone in children on ECMO;CPT: Pharmacometrics & Systems Pharmacology;2024-07-21

4. A guide to developing population files for physiologically‐based pharmacokinetic modeling in the Simcyp Simulator;CPT: Pharmacometrics & Systems Pharmacology;2024-07-18

5. Applying quantitative and systems pharmacology to drug development and beyond: An introduction to clinical pharmacologists;Indian Journal of Pharmacology;2024-07